{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:59:44Z","timestamp":1789516784940,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014605","name":"Sage Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014605","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Compass Pathways"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jad.2025.119655","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T19:10:25Z","timestamp":1749496225000},"page":"119655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression \u2013 12-month data from an open-label pilot study"],"prefix":"10.1016","volume":"389","author":[{"given":"Sara","family":"Ellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Bostian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Lean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Conlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ostacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Aaronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Suppes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jad.2025.119655_bb0005","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1176\/appi.ajp.20231063","article-title":"Single-dose psilocybin for depression with severe treatment resistance: an open-label trial","volume":"182","author":"Aaronson","year":"2024","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.119655_bb0010","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2025.119655_bb0015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2025.119655_bb0020","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2025.119655_bb0025","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.jad.2025.119655_bb0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-2007-979351","article-title":"The standardized psychometric assessment of Altered States of Consciousness (ASCs) in humans","volume":"31","author":"Dittrich","year":"1998","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2025.119655_bb0035","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4088\/JCP.v67n0501","article-title":"Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression","volume":"67","author":"Dunner","year":"2006","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jad.2025.119655_bb0040","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jad.2024.09.133","article-title":"Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression \u2013 a first-in-kind open-label pilot study","volume":"369","author":"Ellis","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.119655_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102799","article-title":"Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial","volume":"76","author":"Erritzoe","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1016\/j.jad.2025.119655_bb0050","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1017\/S1092852924002487","article-title":"Psilocybin and hallucinogenic mushrooms","volume":"29","author":"Fradet","year":"2024","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2025.119655_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.112749","article-title":"The experimental effects of psilocybin on symptoms of anxiety and depression: a meta-analysis","volume":"284","author":"Goldberg","year":"2020","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2025.119655_bb0060","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2025.119655_bb0065","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jad.2024.12.061","article-title":"The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression","volume":"372","author":"Goodwin","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.119655_bb0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/02698811211073759","article-title":"Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: prospective 12-month follow-up","volume":"36","author":"Gukasyan","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.119655_bb0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2025.119655_bb0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jad.2018.06.045","article-title":"The burden of treatment-resistant depression: a systematic review of the economic and quality of life literature","volume":"242","author":"Johnston","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.119655_bb0085","series-title":"Veteran Psychiatry in the US","first-page":"93","article-title":"Treatment-resistant depression among US military veterans","author":"Lande","year":"2019"},{"key":"10.1016\/j.jad.2025.119655_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1134454","article-title":"Therapeutic effect of psilocybin in addiction: a systematic review","volume":"14","author":"van der Meer","year":"2023","journal-title":"Front. Psychiatr."},{"issue":"4","key":"10.1016\/j.jad.2025.119655_bb4000","doi-asserted-by":"crossref","first-page":"19m13038","DOI":"10.4088\/JCP.19m13038","article-title":"Impact of Concurrent Posttraumatic Stress Disorder on Outcomes of Antipsychotic Augmentation for Major Depressive Disorder With a Prior Failed Treatment: VAST-D Randomized Clinical Trial","volume":"81","author":"Mohamed","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.119655_bb0095","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.119655_bb0100","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/mp.2015.92","article-title":"Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder","volume":"20","author":"Papakostas","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2025.119655_bb0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.euroneuro.2023.07.011","article-title":"Psilocybin-assisted therapy for depression: a systematic review and dose-response meta-analysis of human studies","volume":"76","author":"Perez","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.119655_bb0110","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia\u2013Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.119655_bb0115","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2024"},{"key":"10.1016\/j.jad.2025.119655_bb0120","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2025.119655_bb0125","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cpr.2011.07.004","article-title":"Prevalence and clinical course of depression: a review","volume":"31","author":"Richards","year":"2011","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jad.2025.119655_bb0130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jad.2024.04.093","article-title":"The complexity of treatment-resistant depression: a data-driven approach","volume":"358","author":"Rost","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.119655_bb0135","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2025.119655_bb0140","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.119655_bb0145","article-title":"Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases","volume":"2024","author":"Schipper","year":"2024","journal-title":"Cochrane Database Syst. Rev."},{"issue":"16","key":"10.1016\/j.jad.2025.119655_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.jad.2025.119655_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-025-08813-6","article-title":"Psilocybin\u2019s lasting action requires pyramidal cell types and 5-HT2A receptors","author":"Shao","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jad.2025.119655_bb0160","series-title":"Handbook of Psychiatric Measures","first-page":"113","article-title":"Sheehan disability scale","author":"Sheehan","year":"2000"},{"issue":"Suppl. 20","key":"10.1016\/j.jad.2025.119655_bb0165","first-page":"22","article-title":"The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatr."},{"issue":"8023","key":"10.1016\/j.jad.2025.119655_bb0170","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-024-07624-5","article-title":"Psilocybin desynchronizes the human brain","volume":"632","author":"Siegel","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jad.2025.119655_bb0175","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1177\/02698811231154852","article-title":"Psilocybin-assisted therapy for major depressive disorder: an exploratory placebo-controlled, fixed-order trial","volume":"37","author":"Sloshower","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.119655_bb0180","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1080\/03007995.2021.1918073","article-title":"Economic burden of treatment-resistant depression among veterans in the United States","volume":"37","author":"Szukis","year":"2021","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2025.119655_bb0185","article-title":"Development and evaluation of a therapist training program for psilocybin therapy for treatment-resistant depression in clinical research","volume":"12","author":"Tai","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2025.119655_bb0190","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.2105\/AJPH.2015.302836","article-title":"Prevalence, comorbidity, and prognosis of mental health among US veterans","volume":"105","author":"Trivedi","year":"2015","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.jad.2025.119655_bb0195","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/NDT.S198774","article-title":"Management of treatment-resistant depression: challenges and strategies","volume":"16","author":"Voineskos","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"2","key":"10.1016\/j.jad.2025.119655_bb0200","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(15)00495-2","article-title":"Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: follow-up of the CoBalT randomised controlled trial","volume":"3","author":"Wiles","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2025.119655_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02687038.2018.1454884","article-title":"Statistical analysis in Small-N Designs: using linear mixed-effects modeling for evaluating intervention effectiveness","volume":"33","author":"Wiley","year":"2019","journal-title":"Aphasiology"},{"key":"10.1016\/j.jad.2025.119655_bb0210","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jad.2016.07.023","article-title":"Characteristics of U.S. veteran patients with major depressive disorder who require \u201cnext-step\u201d treatments: a VAST-D report","volume":"206","author":"Zisook","year":"2016","journal-title":"J. Affect. Disord."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725010973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725010973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:02:10Z","timestamp":1776920530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725010973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":43,"alternative-id":["S0165032725010973"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.119655","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression \u2013 12-month data from an open-label pilot study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.119655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119655"}}